Dai, Peng http://orcid.org/0000-0002-4581-3473
Wu, Lucia Ruojia http://orcid.org/0000-0001-5051-9685
Chen, Sherry Xi
Wang, Michael Xiangjiang http://orcid.org/0000-0001-7009-6958
Cheng, Lauren Yuxuan http://orcid.org/0000-0001-7692-5446
Zhang, Jinny Xuemeng
Hao, Pengying
Yao, Weijie
Zarka, Jabra http://orcid.org/0000-0001-8668-6741
Issa, Ghayas C. http://orcid.org/0000-0002-4339-8683
Kwong, Lawrence
Zhang, David Yu
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (U01CA233364, R01CA203964)
Cancer Prevention and Research Institute of Texas (RP180147)
Article History
Received: 31 May 2021
Accepted: 30 September 2021
First Online: 21 October 2021
Competing interests
: A US provisional patent application (No. 63/018,922) and an international patent application (No. PCT/US2021/030249) covering the use of QBDA technology have been filed in which the Rice University is the applicant, and D.Y.Z., L.R.W., P.D. and S.X.C. are the inventors. P.D., L.R.W., S.X.C., M.X.W. and L.Y.C. declares a competing interest in the form of consulting for Nuprobe USA. D.Y.Z. declares a competing interest in the form of consulting for and significant equity ownership in Nuprobe USA, Torus Biosystems, and Pana Bio. The remaining authors declare no competing interests.